Navigation Links
Curemark Opens Patient Enrollment for Autism Treatment at Three More Clinical Trial Sites
Date:11/19/2009

RYE, N.Y., Nov. 19 /PRNewswire/ -- Curemark LLC, (www.curemark.com), a drug research and development company focused on the treatment of neurological diseases, announced that the company has begun enrolling patients in Phase III clinical trials for CM-AT, its autism treatment, at three additional clinical trial sites. The sites are the Southwest Autism and Resource Center in Phoenix, Arizona (SARRC); Pennsylvania State University's Pediatric Clinical Research Office at Hershey Medical Center in Hershey Pennsylvania; and the University of North Carolina at Chapel Hill.

Curemark is conducting Phase III clinical trials for CM-AT at 12 sites with a total 170 children across the country. The company previously announced that the first clinical trial patients were enrolled at Lake Mary Pediatrics in Orange City, Florida.

"We are extremely pleased with the progress of the Phase III trial enrollment for CM-AT and are continuing to move forward with the other sites in the study across the country," said Dr. Joan Fallon, Curemark founder and CEO. "Especially given the new data on the increased incidence of autism, we're excited to be this far along in our clinical program."

CM-AT is based on Fallon's breakthrough research that showed enzyme deficiencies in autistic children, resulting in an inability to digest protein. The inability to digest protein affects the production of amino acids, the building blocks of chemicals essential for brain function. CM-AT will be one of the first therapies to address the underlying physiology of autism, rather than just treat its symptoms.

A new study released in early October by the U.S. Centers for Disease Control (CDC) showed that the number of children affected by autism is much higher than originally thought. According to the CDC, autism affects 1 in 91 children and about 1 in 58 boys, totaling an estimated 67
'/>"/>

SOURCE Curemark LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
2. Curemark Announces Senior Executive Promotions
3. Curemark CEO Presents at Epigenomics Conference
4. Curemark Closes Series A Financing
5. Curemark Appoints Preeminent Pediatrics Gastroenterologist
6. Diplomat Specialty Pharmacy Continues to Expand - Opens Location in Southern California
7. Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation
8. Center for Community Health Opens in Skid Row to Provide Healthcare Services to Nearly 9,000 Patients Annually
9. Whistleblowers Attorney Says Pfizers Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies
10. TCP Innovations Opens First US Office
11. New Places and People - Truphatek opens USA subsidiary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Jan. 14, 2014  Luminex Corporation (Nasdaq: LMNX ) ... fourth quarter of 2013 on Monday, February 3, 2014. A ... the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ... discuss the operating highlights and financial results for the fourth ...
(Date:1/14/2014)... Ore. , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s ... a targeting guide with accompanying instrumentation to place and ... adjunct to the soft tissue (e.g. ligament) repair or ... tissue repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
(Date:1/14/2014)... Oligomerix, Inc. , a privately held company pioneering the ... and related neurodegenerative disorders, announced today the relocation of ... as of January 15, 2014 and expanded lease ... College. Oligomerix, which is focused on the ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
(Date:4/17/2014)... study has found that India,s shocking rates of suicide ... who are clinging to tiny smallholdings less than ... such as cotton and coffee, that are highly susceptible ... range of previous case studies that point to a ... the ,liberalisation, of the nation,s economy during the 90s. ...
(Date:4/17/2014)... patients adrenaline after they suffer a cardiac arrest outside ... surviving long-term, according to new research conducted at St. ... have a cardiac arrest get adrenaline, which has been ... said Dr. Steve Lin, an emergency physician and trauma ... medical treatment, long-term survival rates of patients who suffer ...
(Date:4/17/2014)... as the leading weapon against the deadly disease could ... research indicating it simply needs to be administered differently. ... cheap anti-malarial drug chloroquine in treating and preventing the ... half a million people each year around the world. ... to chloroquine, but research carried out at the Australian ...
(Date:4/16/2014)... Consider the marvel of the embryo. It begins as ... as they multiply to become the cells of our lungs, ... body. , Now, in a feat of reverse tissue engineering, ... coding that allows embryonic cells to proliferate and transform into ...
(Date:4/16/2014)... Therapeutics, Inc. (NASDAQ: CLDX) announced today that final data ... tumors, including long-term patient follow-up, have been published in ... The data demonstrate robust antibody and T cell responses ... advanced cancers and suggest that CDX-1401 may predispose patients ...
Breaking Medicine News(10 mins):Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:Adrenaline does little to increase patient's survival after cardiac arrest 2Health News:Scientists find new way to fight malaria drug resistance 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4
... French and Spanish . , Researchers at ... ,gene E, which leads to the death of tumour cells derived from ... this new gene is that its use to fight cancer can reduce ... effective treatment for cancer. This research was conducted by Ana ...
... ... Surgeons (ASPS), are available to discuss the recently proposed cosmetic surgery tax. , ... Arlington Heights, IL (Vocus) ... Surgeons (ASPS), are available to discuss the recently proposed cosmetic surgery tax., , ,WHAT: ...
... ... IVD manufacturers, distributors and industry service providers about the state of their company, international ... ... medical device regulatory consulting firm Emergo Group Inc. recently surveyed medical device and ...
... ... in a national movement to raise awareness for a disease that affects 24 million Americans. ... Richmond, VA (Vocus) November ... recognizes National Diabetes Awareness Month, observed annually during the month of November. Nearly 24 ...
... ... report on how to generate free leads through your website. , ... (PRWEB) November 24, 2009 -- 2009 has been another ... the strain to keep their businesses afloat and reduce costs. Typically the first items on ...
... , RESTON, Va., Nov. 24 Lincoln County ... Maine with two small hospitals and retirement communities, employing more than 1,200 ... you,re not getting successful backup, you,re not doing your job," says Brooks ... case with many hospitals in Maine, budgets are extremely tight for LCH, ...
Cached Medicine News:Health News:Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage 2Health News:Leading Plastic Surgery Experts Available to Discuss Proposed ,Cosmetic Surgery Tax 2Health News:Medical Device Industry Positive About 2010 – Survey 2Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 2Health News:Home Care Delivered, Inc. Recognizes November as National Diabetes Awareness Month 3Health News:We Do Web Content Offers Free Lead Generation Report 2Health News:We Do Web Content Offers Free Lead Generation Report 3Health News:Replay 4 Customer Takes Risk, Fights for Budget to Protect Information Systems 2
HST, multi frequency Side Fire "T intraoperative transducer. A wide field of view is this transducers benefit....
This convex sector mechanical sector transducer provides real-time photo-realistic images....
Wide band, Super High Density endovaginal transducer provides a 180 field of view allowing imaging of the entire uterus and cervix with minimal transducer movement....
Provides tremendous image quality along with a 180 degree field of view....
Medicine Products: